This online course, which includes slides, audio narration, and interactive questions, provides information on how to screen, test, and treat human immunodeficiency virus (HIV)-infected patients for latent tuberculosis infection (LTBI). TB and HIV experts from the Western Region wrote and presented the case-based lessons in this course.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.
The US Agency for International Development (USAID) has reported to Congress on its international foreign assistance efforts to control tuberculosis (TB). Titled Leading and Leveraging, the report documents work completed the previous fiscal year.
This fact sheet presents TB morbidity rates for Hispanic/Latino persons in the United States. These statistics emphasize the need to eliminate TB and to focus on preventing and controlling TB in this minority group.
This report gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.
This Medscape CDC Expert Video Commentary features Dr. Sundari Mase discussing multidrug-resistant tuberculosis (MDR TB) and the recently released CDC guidelines for the use and monitoring of a new TB drug called bedaquiline.
This online course discusses critical principles and steps to facilitate treatment adherence for MDR-TB patients. The five A’s are: Assess, Advise, Agree, Arrange, and Assist.
This handbook provides detailed examples of the analysis of TB surveillance data, in particular TB notification data, data from surveillance of anti-TB drug resistance, and mortality data compiled in national vital registration systems.
This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
